Thomas Zimmermann - Net Worth and Insider Trading
Thomas Zimmermann Net Worth
The estimated net worth of Thomas Zimmermann is at least $0 dollars as of 2024-09-19. Thomas Zimmermann is the Chief Financial Officer of Apontis Pharma AG and owns about 0 shares of Apontis Pharma AG (XTER:APPH) stock worth over $0. Details can be seen in Thomas Zimmermann's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Thomas Zimmermann has not made any transactions after 2024-05-08 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Thomas Zimmermann
Thomas Zimmermann Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Thomas Zimmermann owns 1 companies in total, including Apontis Pharma AG (XTER:APPH) .
Click here to see the complete history of Thomas Zimmermann’s form 4 insider trades.
Insider Ownership Summary of Thomas Zimmermann
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| XTER:APPH | Apontis Pharma AG | 2024-05-08 | Chief Financial Officer |
Thomas Zimmermann Latest Holdings Summary
Thomas Zimmermann currently owns a total of 1 stock. Thomas Zimmermann owns 0 shares of Apontis Pharma AG (XTER:APPH) as of May 8, 2024, with a value of $0.
Latest Holdings of Thomas Zimmermann
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| XTER:APPH | Apontis Pharma AG | 2024-05-08 | 0 | 6.96 | 0 |
Holding Weightings of Thomas Zimmermann
Thomas Zimmermann Form 4 Trading Tracker
According to the SEC Form 4 filings, Thomas Zimmermann has made a total of 5 transactions in Apontis Pharma AG (XTER:APPH) over the past 5 years, including 5 buys and 0 sells. The most-recent trade in Apontis Pharma AG is the acquisition of 1,200 shares on May 8, 2024, which cost Thomas Zimmermann around $10,128.
Insider Trading History of Thomas Zimmermann
- 1
Thomas Zimmermann Trading Performance
GuruFocus tracks the stock performance after each of Thomas Zimmermann's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Thomas Zimmermann is -11.32%. GuruFocus also compares Thomas Zimmermann's trading performance to market benchmark return within the same time period. The performance of stocks bought by Thomas Zimmermann within 3 months outperforms 0 times out of 5 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Thomas Zimmermann's insider trading performs compared to the benchmark.
Performance of Thomas Zimmermann
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 3 |  | | | | |
| Relative Return to S&P 500(%) | -0.07 | | | | | |
Thomas Zimmermann Ownership Network
Thomas Zimmermann Owned Company Details
What does Apontis Pharma AG do?
Who are the key executives at Apontis Pharma AG?
Thomas Zimmermann is the Chief Financial Officer of Apontis Pharma AG. Other key executives at Apontis Pharma AG include Board of Directors Thomas Milz , Board of Directors Bruno Wohlschlegel , and Board of Directors Karlheinz Gast .
Apontis Pharma AG (XTER:APPH) Insider Trades Summary
Over the past 18 months, Thomas Zimmermann made 5 insider transaction in Apontis Pharma AG (XTER:APPH) with a net purchase of 2,200. Other recent insider transactions involving Apontis Pharma AG (XTER:APPH) include a net purchase of 3,000 shares made by Thomas Milz , a net purchase of 5,000 shares made by Karlheinz Gast , and a net purchase of 1,000 shares made by Bruno Wohlschlegel .
In summary, during the past 3 months, insiders sold 0 shares of Apontis Pharma AG (XTER:APPH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Apontis Pharma AG (XTER:APPH) were sold and 11,200 shares were bought by its insiders, resulting in a net purchase of 11,200 shares.
Apontis Pharma AG (XTER:APPH)'s detailed insider trading history can be found in Insider Trading Tracker table.
Apontis Pharma AG Insider Transactions
Thomas Zimmermann Mailing Address
Above is the net worth, insider trading, and ownership report for Thomas Zimmermann. Currently GuruFocus does not have mailing address information for Thomas Zimmermann.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
